OMAPREM contains Omega 3 fatty acids DHA and EPA and is the ONLY product containing 30 essential fatty acids. This diverse combination of essential fatty acids is what makes OMAPREM so unique and is backed by over 25 years of multiple clinical studies.
OMAPREM uses New Zealand green-lipped mussels with the highest concentrations of SPM content. In clinical studies, the active ingredient in OMAPREM (PCSO-524) has been shown to support joint mobility and respiratory function.
Omega 3s are anti-inflammatory because they convert to SPMs which have anti-inflammatory, neuroinflammation-reducing, and pain-reducing benefits.
OMAPREM has a higher concentration of the SPM metabolite so the body needs less conversion to feel the benefits of reduced inflammation.
